AWARD
A -- Development of a Rapidly-acting Preventative Therapy for Influenza
- Notice Date
- 7/16/2019
- Notice Type
- Award
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- 675 North Randolph Street Arlington VA 22203-2114
- ZIP Code
- 22203-2114
- Solicitation Number
- HR001118S0037
- Archive Date
- 7/26/2019
- Point of Contact
- Dr. Robert Debs, CEO
- E-Mail Address
-
bob@dnarx.net
- Award Number
- HR001119C0060
- Award Date
- 4/9/2019
- Awardee
- DNARX LLC, 235 Berry St. Apt 610, San Francisco, CA 94158 US
- Award Amount
- $3,598,132 Base and $7,115,237 NTE Options
- Line Number
- 0001-0004
- Description
- This is an award annoucement only under the PReemptive Expression of Protective Alleles and Response Elements (PREPARE) BAA. The BAA is closed. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (16-JUL-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/ODA/DARPA/CMO/Awards/HR001119C0060.html)
- Record
- SN05372132-F 20190718/190716230108 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |